Leukemia is relatively rare compared to most other cancers, and is currently the 11th most common. According to the SEER 2008-2010 data, about 1.4 percent of men and women will be diagnosed with leukemia at some point during their lifetime.
Although rare compared to other cancers, acute leukemia is the most common cancer among children.
The 5 year survival rate of leukemia (overall) is 57.2%.
Leukemia can be classified into 2 basic groups—the acute and the chronic leukemias. Acute types include: Acute myeloid leukemia (AML), Acute lymphoblastic leukemia (ALL), and Adult T-cell Leukemia/Lymphoma. Chronic leukemias include Chronic lymphocytic leukemia (CLL), Chronic myelogenous leukemia (CML), and Hairy Cell leukemia. Leukemia is a type of blood cancer that begins in the bone marrow and affects the white blood cells or leukocytes (which include neutrophils, basophils, eosinophils, monocytes, and lymphocytes).
Among the most well-established risk factors include:
Other risk factors include:
Labs will likely be ordered by your physician to assess red and white blood cell status and platelet count.
If leukemia is suspected then a bone marrow aspiration and biopsy may be performed, which is a test that looks for malignant cells in the bone marrow as well as certain changes in the cell chromosomes from a sample of blood or bone marrow (cytogenetic analysis).
A test to look for genes that are “turned on” in several types of leukemia, such as acute myelogenous leukemia (AML) called reverse transcription-polymerase chain reaction test, or RT-PCR.
A test that compares the cancerous cells to normal blood cells to find the specific kind of leukemia, or immunophenotyping.
Multiple nutritional supplements have been associated with reduced cancer incidence and/or cancer progression. The list below contains those with the greatest evidence-base and benefit, though it is not necessary that they all be included.
 http://seer.cancer.gov/statfacts/html/leuks.html Accessed August 2014
 Sheng X1, Mittelman SD2. The role of adipose tissue and obesity in causing treatment resistance of acute lymphoblastic leukemia. Front Pediatr. 2014 Jun 5;2:53. doi: 10.3389/fped.2014.00053. eCollection 2014.
 Shih TY, Wu J, Muo CS, Kao CH. Association between leukaemia and X-ray in children: A nationwide study. J Paediatr Child Health. 2014 Aug;50(8):615-8. doi: 10.1111/jpc.12605. Epub 2014 Jun 9.
 Gillies M, Haylock R. The cancer mortality and incidence experience of workers at British Nuclear Fuels plc, 1946-2005. J Radiol Prot. 2014 Jul 22;34(3):595-623.
 Deziel NC, Rull RP, Colt JS, Reynolds P, Whitehead TP, Gunier RB, Month SR, Taggart DR, Buffler P, Ward MH, Metayer C. Polycyclic aromatic hydrocarbons in residential dust and risk of childhood acute lymphoblastic leukemia. Environ Res. 2014 Aug;133:388-95. doi: 10.1016/j.envres.2014.04.033. Epub 2014 Jun 17.
 Wiemels J. Perspectives on the causes of childhood leukemia. Chem Biol Interact. 2012 Apr 5;196(3):59-67. doi: 10.1016/j.cbi.2012.01.007. Epub 2012 Feb 2.
 Milne E1, Greenop KR, Scott RJ, et al. Parental prenatal smoking and risk of childhood acute lymphoblastic leukemia. Am J Epidemiol. 2012 Jan 1;175(1):43-53. doi: 10.1093/aje/kwr275.
 Lee KM1, Ward MH, Han S, et al. Paternal smoking, genetic polymorphisms in CYP1A1 and childhood leukemia risk. Leuk Res. 2009 Feb;33(2):250-8. doi: 10.1016/j.leukres.2008.06.031. Epub 2008 Aug 8.
 Järvelä LS1, Niinikoski H, Heinonen OJ, et al. Endothelial function in long-term survivors of childhood acute lymphoblastic leukemia: effects of a home-based exercise program. Pediatr Blood Cancer. 2013 Sep;60(9):1546-51. doi: 10.1002/pbc.24565. Epub 2013 Apr 20.
 Chiang J, Huang YW, Chen ML, Wang SY, Huang AC, Chen YJ. Comparison of anti-leukemic immunity against U937 cells in endurance athletes versus sedentary controls. Int J Sports Med. 2000 Nov;21(8):602-7.